A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
Stopped Due to a change in the development program, the study was closed prematurely.
Conditions
- Uterine Fibroids and Heavy Menstrual Bleeding
Interventions
- DRUG: Vilaprisan (BAY1002670)
Sponsor
Bayer